Hello, Fool! | Login | Signup | My Fool
Oct 12, 2008 4:43 AM ET | Feedback | Site Changes | Help
The Company designs, manufactures, markets and services a range of proprietary products that can improve clinical outcomes and can help reduce the overall cost of patient care.ÂÂ
View All Commentary (KCI)
Recs
pennysplants (99.81) Submitted: 6/19/08 5:43 PM : Start Price: $40.74 KCI Score: -10.92
The Lifecell acquisition (and large short position) will probably play havoc with this stock in the short term. However, I think a healthy company + healthy niche = GOOD long term potential.(And I like the recent "gender neutral" board recommendations) !! Sorry, folks. I watch this type of stuff, too. Insight into management, don't you know. Yeah, woman CEO. A bonus.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.